Navigation Links
Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
Date:2/4/2008

excellent working relationship with AAFC.

Mr. Wei Li, Chairman of the Board and CEO of the Company, stated, "Through these meetings, Kiwa has established good relations with Canadian government agencies, technology development organizations and commercial operations with the Canadian agricultural industry. This lays the groundwork for future discussions."

About Natunola Health Inc.

The Canadian company based in Ottawa, Ontario is becoming a leading supplier of botanical ingredients to the cosmetic industry as well as shelled flaxseed to the food industry.

Thanks to its patented technologies, in particular its Vegetable Gel Technology, Natunola is able to offer health conscious consumers a unique natural alternative to petroleum-based ingredients. Natunola offers its customers vegetable gels based on canola, sunflower, castor and rice bran oils, as well as customized ingredients.

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( http://www.sec.gov ) or visit the Company's website at

SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007
2. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
3. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
4. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
5. Kiwa Bio-Tech Third Quarter Revenues Increase 226% - Nine-Month Revenues $6.2 Million
6. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
7. Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month
8. Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
9. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... BEACH, Calif. , July 28, 2015 /PRNewswire-USNewswire/ ... announced that it has hit a milestone of ... Signafuse was FDA 510(k) cleared in early 2014 ... use in posterolateral spine fusion procedures.  This is ... products, as less than 6% of new synthetic ...
(Date:7/28/2015)... N.C., July 28, 2015  United Therapeutics Corporation (NASDAQ: ... for the second quarter ended June 30, 2015. ... compared to the second quarter of 2014 when ... Ph.D., United Therapeutics, President and Co-Chief Executive Officer. ... an increase in the number of patients being ...
(Date:7/27/2015)... , July 27, 2015  Amgen (NASDAQ: ... second quarter financial results on Thursday, July 30, 2015, ... announcement will be followed by a conference call with ... the call from Amgen will be Robert A. ... members of Amgen,s senior management team. Live ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is a ... provides a basic overview of the industry including definitions, classifications, applications and industry ... development trends, competitive landscape analysis, and key regions development status. Development policies and ...
Breaking Biology Technology:Revolutionary Bone Graft Exceeds Expectations 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Amgen Announces Webcast of 2015 Second Quarter Financial Results 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3
... - Anavex Life,Sciences Corp. ("ANAVEX") (OTCBB: AVXL) today ... significantly delay the growth of cancerous,tumors in patient-derived ... were developed in ANAVEX labs using a sample,taken ... Clear cell sarcoma,is a rare type of melanoma ...
... YWCA & Roche to Educate Patients on, How ... a Career -, NEW YORK, March 10 ... a non-profit program,founded by Cosmetic Executive Women Foundation, and ... hundreds of thousands of people,living with cancer on how ...
... PINE BROOK, N.J., March 10 Elusys Therapeutics, ... for the treatment of life-threatening infectious,diseases, today announced ... President of Research., Elizabeth G. Posillico, Ph.D., ... "On behalf of Elusys, Board of Directors and,management, ...
Cached Biology Technology:Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 2Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 3Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 4Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 5Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity 6First-Ever 'Cancer and Careers' Seminar Debuts in Orange County 2First-Ever 'Cancer and Careers' Seminar Debuts in Orange County 3Elusys Therapeutics Appoints Robert Gundel as Vice President of Research 2
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... cells influenced by embryonic stem cell-derived cells can help ... without the use of immunosuppressive drugs. The University ... Medical Center finding has implications for possible improvements in ... results appeared Friday in the online journal PLoS ...
... MABrandeis University has won a highly competitive $7.8 ... establish a Materials Research Science and Engineering Center ... imposing constraints on materials, such as DNA confined ... of rod-like virus particles, as a guide to ...
... 2008 Selenium has been referred to as an "essential ... a marginal line between the nutritious requirement and toxic ... to bioaccumulation effects have lead to the characterization of ... by exceeding a narrow threshold concentration in ecosystems through ...
Cached Biology News:Embryonic stem cells might help reduce transplantation rejection 2New research center at Brandeis to combine materials science and biology 2New research center at Brandeis to combine materials science and biology 3Biological selenium removal: The solution to pollution? 2
Request Info...
... Gelzyme is an agarose-digesting enzyme isolated ... simple carbohydrate bonds in agarose producing ... gel. The remaining carbohydrate molecules will ... DNA isolated with Gelzyme enzyme can ...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Biology Products: